Comparison 4. Nevirapine once daily versus efavirenz.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Treatment failure on or before week 48 | 1 | 620 | Risk Ratio (M‐H, Random, 95% CI) | 1.16 [0.95, 1.41] |
2 Undetectable plasma HIV RNA < 50 copies/ml at 48 weeks | 1 | 620 | Risk Ratio (M‐H, Random, 95% CI) | 1.0 [0.90, 1.11] |
3 Death | 1 | 620 | Risk Ratio (M‐H, Random, 95% CI) | 1.82 [0.65, 5.12] |